Clinical Trials Browser

Interventional × IPH-2101 × Plasma cell × Clear all

NCT00552396 2016-03-31

An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma

Phase 1 Completed

32 enrolled 16 charts

Multiple Myeloma

NCT00999830 2016-03-24

REMYKIR

Phase 2 Completed

27 enrolled 10 charts

Multiple Myeloma

NCT01222286 2014-05-09

KIRMONO

Phase 2 Completed

30 enrolled 10 charts

Smoldering Multiple Myeloma